Endocrine therapy: predictors of response to prostatic cancer.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D002467:Cell Nucleus / Q000032:analysis; D003600:Cytosol / Q000032:analysis; D013196:Dihydrotestosterone / Q000032:analysis; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000032:analysis; D011471:Prostatic Neoplasms / Q000032:analysis / Q000188:drug therapy*; D011944:Receptors, Androgen / Q000032:analysis
D000726:Androgen Antagonists; D011944:Receptors, Androgen; D013196:Dihydrotestosterone